MoneyWorks4Me

Lincoln Pharmaceuticals informs about statement of investor complaints

10 Jan 2018 Evaluate

Lincoln Pharmaceuticals has informed about the Copy of Investors Complaints for the Quarter Ended on December 31, 2017.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..